Feline Eosinophilic
Granuloma Complex: An Overview
Tricia A. Starnes,
DVM; Kenneth S. Latimer, DVM, PhD; Pauline M. Rakich, DVM, PhD; Perry
J. Bain, DVM, PhD
Class of 2003 (Starnes),
Department of Pathology (Latimer, Bain), and Athens Veterinary Diagnostic
Laboratory (Rakich), College of Veterinary Medicine, The University
of Georgia, Athens, GA 30602-7388

Introduction
Feline eosinophilic
granuloma complex (EGC) is a common inflammatory skin disease of
cats, which consists of a group of lesions that affect the skin,
mucocutaneous junctions, and oral cavity. EGC is not a specific disease
but simply several cutaneous reaction patterns in cats.5-7 Classically,
three lesions have been characterized in feline EGC: (1) the indolent
ulcer, (2) the eosinophilic plaque, and (3) the eosinophilic granuloma.1,3,6 These
lesions are grouped together because they may occur in the same patient
and may respond to the same therapy.2,3,5,7
There are no breed
predilections to EGC, but females may be predisposed to development
of lesions.3,5-7 Young to middle-age cats usually
are affected (average age 3.5 years)3,4,7 and peripheral
lymphadenopathy is often associated with these dermatoses.4,6,7 Long-standing
and more extensive EGC is associated with chronic immune stimulation
and an ensuing polyclonal gammopathy.3
The cause of EGC
is unknown; however, an underlying hypersensitivity such as a food
allergy, atopy, or insect allergy (particularly to fleas and mosquitoes)
often has been associated with these lesions.4,6,7 Since
antibiotic therapy clears or significantly improves some lesions,
bacterial infection also may be implicated.6 However,
the response to antibiotics may be due to the immune-modulating effects
of the antibiotic therapy rather than any antibacterial properties.7 A
genetic predisposition to EGC may exist because eosinophilic granulomas
and indolent ulcers have been observed in a colony of specific pathogen-free
cats and other cats with limited genetic diversity.2,6 Also,
it has been postulated that EGC may be an autoimmune phenomenon because
the presence of circulating antiepithelial autoantibodies has been
demonstrated in one study of affected cats.2 Conversely,
due to the severe epidermal injury and dermal reaction in cats with
EGC, altered antigens may have been released resulting in production
of autoantibody.2
The main pathogenic
events in these lesions are most likely caused by eosinophil recruitment
and degranulation.1 Circulating eosinophils move into
tissues (especially into subepithelial sites) in reaction to inflammation
prompted by antigen-antibody complexes, parasites, or microorganisms
(Fig. 1).7 Since eosinophils are attracted to and phagocytize
antigen-antibody complexes, the presence of eosinophils in the EGC
indicates that it is an immune-mediated disease.2
Many other diseases
may have a similar clinical presentation as EGC. Due to the correlation
with hypersensitivity disorders, a diagnostic evaluation for allergic
skin disease should be conducted.7 Diagnostic tests may
be comprised of intradermal skin testing, a hypoallergenic food trial,
a flea control trial, and avoidance of mosquitoes.5,7 These
tests are most commonly performed when EGC is non-responsive to glucocorticoid
therapy. Other differential diagnoses to consider are infectious
ulcers or granulomas (bacterial, fungal, FeLV-associated) and trauma.4,6 In
addition, the clinical appearance of several tumors (squamous cell
carcinoma, mast cell tumor, lymphoma, fibrosarcoma, and mammary carcinoma)
may be similar to granulomas.6,7 Cytology and / or biopsy
specimens are recommended to exclude neoplasia when any cutaneous
mass is evaluated.
 |
| Figure
1. Eosinophil from blood of a cat. Notice the characteristic
rod- or brick-shaped granules (Wright-Leishman stain). |
Dermatohistopathology
The clinical features
of EGC cannot be predicted consistently by the histopathological
findings of the disease complex and vice versa.1,7 The
three clinical varieties of EGC have common histopathological features;
however, unique clinical and histopathological characteristics of
the three elements of EGC also have been described.1,7 A
retrospective study was performed on skin samples from 24 cats with
EGC. Flame figures and/or large foci of collagen degeneration were
seen in every sample.1 Flame figures are small foci of
collagen degeneration in which degenerated collagen fibers are surrounded
by degranulated eosinophils.1 It has been suggested that
the use of the terms eosinophilic plaque, indolent ulcer, and eosinophilic
granuloma be restricted to clinical dermatology, while the term eosinophilic
dermatoses should be used in diagnostic dermatopatholgy.1
Feline
Indolent Ulcer
(Eosinophilic Ulcer, Rodent Ulcer)
Clinical
Presentation
Feline indolent
ulcer is a common cutaneous, mucocutaneous, and oral mucosal lesion.
Although, most indolent ulcers occur unilaterally on the upper lip,
they also may appear bilaterally in the oral cavity or in other cutaneous
locations (Fig. 2).4-7 Typically, the lesions are well-circumscribed
with a raised margin and appear red-brown, alopecic, and glistening.6,7 These
ulcers are painless, non-pruritic, and do not bleed.1,4-7 Lip
ulcers rarely may undergo malignant transformation into squamous
cell carcinoma.5-7
 |
| Figure
2. Feline indolent ulcer of the upper lip (© Bristol
Biomedical Image Archive, University of Bristol). |
Diagnosis
Biopsy is nondiagnostic
and reveals a hyperplastic, ulcerated, superficial perivascular to
interstitial dermatitis (typically with a preponderance of neutrophils
and mononuclear cells) and fibrosis.1,4,6 Biopsy is primarily
used to exclude malignancy.5 Eosinophilia rarely is observed
in the blood.4,6
Feline
Eosinophilic Plaque
Clinical
Presentation
Feline eosinophilic
plaque is a common cutaneous lesion which may arise anywhere on the
skin, but is most commonly found on the ventral abdomen and medial
thighs (Fig. 3).4,6,7 The plaques may be single or multiple
and measure 0.5 to 7.0 cm in diameter.6 They are well
circumscribed, raised, round to oval, erythematous, moist, and often
ulcerated.5-7 Pruritus usually is severe.4-7 The
moist character of the lesions is due to ulceration.7
 |
| Figure
3. Eosinophilic plaques of the medial thighs and groin.
Lesions are raised, circumscribed to coalescing, erythematous,
and moist. |
Diagnosis
Eosinophils are
observed commonly on cytologic imprints, but neutrophils and bacteria
may prevail if the lesion is secondarily infected.4 Biopsy
findings are variable and may range from a hyperplastic, superficial
and deep, perivascular dermatitis with eosinophilia to interstitial
or diffuse eosinophilic dermatitis.1,4,6 Flame figures
may be observed.1,6 Diffuse spongiosis may be present
in the epidermis.6 Eosinophilia is common in peripheral
blood.4-6
Feline
Eosinophilic Granuloma
(Linear Granuloma,
Collagenolytic Granuloma)
Clinical
Presentation
Eosinophilic granulomas
occur on the caudal thighs, face, and oral cavity (particularly the
tongue and palate, Figs. 4 and 5).4,6,7 Lesions also have
been reported on the footpad.1,7 Cutaneous lesions are
typically well-circumscribed, raised, firm, alopecic, erythematous
plaques with a characteristic linear configuration.5-7 These
lesions generally are non-painful and non-pruritic.4-7 Lesions
on the face and in the oral cavity have a papular to nodular configuration
and are a common reason for lower lip swellings (pouting cats) and
asymptomatic swollen chins (fat-chinned cats, feline chin edema).6 If
the surface is eroded or ulcerated, a distinctive speckling with
pinpoint white foci may be evident.6 Cats with oral lesions
may be dysphagic.4,5,7
 |
 |
| Figure
4. Eosinophilic granuloma of the digit (© Bristol
Biomedical Image Archive, University of Bristol). |
Figure
5. Oral eosinophilic granuloma (© Bristol Biomedical
Image Archive, University of Bristol). |
Diagnosis
Eosinophils are
seen commonly in cytologic imprints, but neutrophils and bacteria
may prevail if the granuloma is secondarily infected.4 Nodular
to diffuse granulomatous dermatitis with multifocal areas of flame
figure formation are visible in biopsy specimens.6 Eosinophils,
histiocytes, and multinucleated giant cells4,6,7 with
foci of collagen degeneration4 are typical (Fig. 6). Mast
cell hyperplasia may be observed occasionally, especially with the
application of metachromatic stains (e.g., Giemsa or toluidine
blue stains, Fig. 7) Dermal foci of amorphous to granular, eosinophilic
to partly basophilic debris are described as being characteristic
histopathological traits of eosinophilic granulomas.1 In
chronic lesions, eosinophils are not as prevalent.6 Eosinophilia
may occur in the blood (especially with oral lesions).6,7
 |
 |
| Figure
6. Histologic section of a cutaneous eosinophilic
granuloma with eosinophils, macrophages, and flame figures
(hematoxylin & eosin stain). |
Figure
7. Histologic section of a cutaneous eosinophilic
granuloma with mast cell hyperplasia. Mast cells contain many
purple cytoplasmic granules (Giemsa stain). |
Treatment
of EGC Dermatoses
| Note:
Treatment of animals should only be performed by a licensed
veterinarian. Veterinarians should consult the current literature
and current pharmacological formularies before initiating any
treatment protocol. |
Identification
and treatment of any suspected underlying disease should be performed
when managing the various forms of feline EGC.4,5 Immunosuppressive
therapy is the most common treatment and systemic glucocorticoids
are often effective. Cats have fewer steroid receptors on their cells
and thus require higher doses of glucocorticoids than most other
species.7 Prednisone or prednisolone may be given orally
(4.4 mg/kg every 24 hours) until the lesions are healed.5-7 Alternatively,
injections of methylprednisolone acetate (20 mg/cat subcutaneously
every 2 -3 weeks until lesions resolve), 4,6,7 or oral
administration of glucocorticoids (dexamethasone at 0.4 mg/kg every
24 hours or triamcinolone at 0.8mg/kg every 24 hours) may be effective.6 Recurrent
lesions may be managed with oral glucocorticoids given every other
day or repeated subcutaneous injections of methylprednisolone (which
should never be given more frequently than every 2 months).6 Considerable
improvement of the lesions should be evident within 2-4 weeks.4 When
the lesions have improved, glucocorticoid therapy should be gradually
tapered to the lowest possible dosage.4,6 Omega-3/omega-6
fatty acid containing products have been shown to be useful in some
cats and reduce glucocorticoid requirements in others.6
For lesions that
are not responsive to steroid therapy, immunomodulation may be considered
as an alternative therapy.3,5,7 Some cats respond to systemic
antibiotics given for 2-3 weeks.4-7 Other immunomodulating
drugs include chlorambucil,4 levamisole, thiabendazole, and
alpha-interferon.6 However, some studies indicate that
alpha-interferon is not as useful in treatment of eosinophilic plaques
and granulomas.6 Other modes of treatment that occasionally
are effective include radiotherapy, cryosurgery, laser therapy, surgical
excision, and mixed bacterial vaccines.3,5-7 In addition,
unpublished reports demonstrate that occlusive biosynthetic absorbent
wound dressing applied to lesions for 48 hours may be beneficial.6,7 The
lesions exhibit a discernible decrease in pruritus following
application.7 Progestational compounds, such as megestrol
acetate, also have been used successfully; however, these drugs are
not recommended due to their adverse side effects.6,7
Prognosis
The prognosis of
ECG is variable. Young cats often have a better prognosis. In cats
less than 1 year of age, eosinophilic granulomas may regress spontaneously
over a period of 3 to 5 months.4,6 In individuals with
recurring lesions without a determined underlying cause, long-term
therapy typically is required to keep the lesions in remission. Since
these cats may become refractory to or develop side effects from
medical therapy a poorer prognosis is given.4
References
1. Fondati A, Fondevila
D, Ferrer L: Histopathological study of feline eosinophilic dermatoses. Vet
Dermatol 6:333-338, 2001.
2. Gelberg HB,
Lewis RM, Felsburg PJ, Smith CA: Antiepithelial autoantibodies associated
with the feline eosinophilic granuloma complex. Am J Vet Res 46:263-265,
1985.
3. MacEwen EG,
Hess PW: Evaluation of effect of immunomuodulation on the feline
eosinophilic granuloma complex. J Am Anim Hosp Assoc 23:519-525,1987.
4. Medleau L, Hnilica
K. Small Animal Dermatology: A Color Atlas and Therapeutic Guide.
WB Saunders, Philadelphia, 2001, pp. 254-258.
5. Merchant SR:
Diagnosis of feline skin disease based on cutaneous reaction patterns. Compend
Contin Educ Pract Vet 16:163,165-166, 1994.
6. Scott DW, Miller
WH, Griffin CE: Small Animal Dermatology. WB Saunders, Philadelphia,
2001, pp. 1148-1153.
7. Song MD: Diagnosing
and treating feline eosinophilic granuloma complex. Vet Med 89:1141-1145,
1994. |